| Ident. | Authors (with country if any) | Title |
|---|
| 000006 (2020) |
J. Reina [Espagne] | [Remdesivir, the antiviral hope against SARS-CoV-2]. |
| 000007 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
| 000025 (2020) |
Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite] | Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. |
| 000033 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000067 (2020) |
Nathan Ford [Suisse] ; Marco Vitoria [Suisse] ; Ajay Rangaraj [Suisse] ; Susan L. Norris [Suisse] ; Alexandra Calmy [Suisse] ; Meg Doherty [Suisse] | Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. |
| 000071 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000091 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
| 000129 (2020) |
Zachary J. Sandler [États-Unis] ; Mason R. Firpo [États-Unis] ; Oreoluwa S. Omoba [États-Unis] ; Michelle N. Vu [États-Unis] ; Vineet D. Menachery [États-Unis] ; Bryan C. Mounce [États-Unis] | Novel ionophores active against La Crosse virus identified through rapid antiviral screening. |
| 000135 (2020) |
Shibo Jiang [République populaire de Chine] ; Christopher Hillyer [États-Unis] ; Lanying Du [États-Unis] | Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. |
| 000199 (2020) |
Xu Qian [République populaire de Chine] ; Ran Ren [République populaire de Chine] ; Youfa Wang [République populaire de Chine] ; Yan Guo [République populaire de Chine] ; Jing Fang [République populaire de Chine] ; Zhong-Dao Wu [République populaire de Chine] ; Pei-Long Liu [République populaire de Chine] ; Tie-Ru Han [République populaire de Chine] | Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind |
| 000225 (2020) |
Manojit Bhattacharya [Corée du Sud] ; Ashish R. Sharma [Corée du Sud] ; Prasanta Patra [Inde] ; Pratik Ghosh [Inde] ; Garima Sharma [Corée du Sud] ; Bidhan C. Patra [Inde] ; Sang-Soo Lee [Corée du Sud] ; Chiranjib Chakraborty [Corée du Sud] | Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. |
| 000249 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
| 000254 (2020) |
Timothy P. Sheahan [États-Unis] ; Amy C. Sims [États-Unis] ; Sarah R. Leist [États-Unis] ; Alexandra Sch Fer [États-Unis] ; John Won [États-Unis] ; Ariane J. Brown [États-Unis] ; Stephanie A. Montgomery [États-Unis] ; Alison Hogg [États-Unis] ; Darius Babusis [États-Unis] ; Michael O. Clarke [États-Unis] ; Jamie E. Spahn [États-Unis] ; Laura Bauer [États-Unis] ; Scott Sellers [États-Unis] ; Danielle Porter [États-Unis] ; Joy Y. Feng [États-Unis] ; Tomas Cihlar [États-Unis] ; Robert Jordan [États-Unis] ; Mark R. Denison [États-Unis] ; Ralph S. Baric [États-Unis] | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV |
| 000262 (2020) |
Junghyun Goo [Corée du Sud] ; Yuji Jeong [Corée du Sud] ; Young-Shin Park [Corée du Sud] ; Eunji Yang [Corée du Sud] ; Dae-Im Jung [Corée du Sud] ; Semi Rho [Corée du Sud] ; Uni Park [Corée du Sud] ; Hyeyeong Sung [Corée du Sud] ; Pil-Gu Park [Corée du Sud] ; Jung-Ah Choi [Corée du Sud] ; Sang Hwan Seo [Corée du Sud] ; Nam Hyuck Cho [Corée du Sud] ; Hyeja Lee [Corée du Sud] ; Jae Myun Lee [Corée du Sud] ; Jae-Ouk Kim [Corée du Sud] ; Manki Song [Corée du Sud] | Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein |
| 000295 (2020) |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| 000329 (2019) |
Leon Chien-Wei Lin ; Chen-Yu Huang ; Bing-Yu Yao ; Jung-Chen Lin ; Anurodh Agrawal ; Abdullah Algaissi ; Bi-Hung Peng ; Yu-Han Liu ; Ping-Han Huang ; Rong-Huay Juang ; Yuan-Chih Chang ; Chien-Te Tseng ; Hui-Wen Chen ; Che-Ming Jack Hu | Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus |
| 000383 (2019) |
Wenxu Jia [République populaire de Chine] ; Rudragouda Channappanavar [États-Unis] ; Chao Zhang [République populaire de Chine] ; Mingxi Li [République populaire de Chine] ; Haixia Zhou [République populaire de Chine] ; Shuyuan Zhang [République populaire de Chine] ; Panpan Zhou [République populaire de Chine] ; Jiuyang Xu [République populaire de Chine] ; Sisi Shan [République populaire de Chine] ; Xuanling Shi [République populaire de Chine] ; Xinquan Wang [République populaire de Chine] ; Jincun Zhao [République populaire de Chine] ; Dongming Zhou [République populaire de Chine] ; Stanley Perlman [États-Unis, République populaire de Chine] ; Linqi Zhang [République populaire de Chine] | Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection |
| 000407 (2019) |
Chean Yeah Yong [Malaisie] ; Hui Kian Ong [Malaisie] ; Swee Keong Yeap [Malaisie] ; Kok Lian Ho [Malaisie] ; Wen Siang Tan [Malaisie] | Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus |
| 000418 (2019) |
Emmie De Wit [États-Unis] ; Friederike Feldmann [États-Unis] ; Eva Horne [États-Unis] ; Atsushi Okumura [États-Unis] ; Elisabetta Cameroni [Suisse] ; Elaine Haddock [États-Unis] ; Greg Saturday [États-Unis] ; Dana Scott [États-Unis] ; Robin Gopal [Royaume-Uni] ; Maria Zambon [Royaume-Uni] ; Davide Corti [Suisse] ; Heinz Feldmann [États-Unis] | Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset |
| 000440 (2019) |
Mohammad Amin Behzadi ; Victor H. Leyva-Grado | Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections |
| 000518 (2019) |
Ernest Tambo [Arabie saoudite] ; Ashraf G. El Dessouky [Arabie saoudite] ; Emad I. M. Khater [Arabie saoudite] | Innovative Preventive and Resilience Approaches Against Aedes-linked Vector-borne Arboviral Diseases Threat and Epidemics Burden in Gulf Council Countries |
